INVO Fertility ROA 2011-2025 | IVF
Current and historical return on assets (ROA) values for INVO Fertility (IVF) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| INVO Fertility ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-06-30 | $-0.03B | $0.02B | -98.25% |
| 2025-03-31 | $-0.03B | $0.03B | -88.50% |
| 2024-12-31 | $-0.01B | $0.05B | -40.40% |
| 2024-09-30 | $-0.01B | $0.02B | -44.44% |
| 2024-06-30 | $-0.01B | $0.02B | -37.84% |
| 2024-03-31 | $-0.01B | $0.02B | -44.44% |
| 2023-12-31 | $-0.01B | $0.02B | -62.75% |
| 2023-09-30 | $-0.01B | $0.02B | -100.00% |
| 2023-06-30 | $-0.01B | $0.01B | -200.00% |
| 2023-03-31 | $-0.01B | $0.01B | -228.57% |
| 2022-12-31 | $-0.01B | $0.00B | -200.00% |
| 2022-09-30 | $-0.01B | $0.01B | -120.00% |
| 2022-06-30 | $-0.01B | $0.01B | -96.97% |
| 2022-03-31 | $-0.01B | $0.01B | -75.68% |
| 2021-12-31 | $-0.01B | $0.01B | -63.16% |
| 2021-09-30 | $-0.01B | $0.01B | -102.56% |
| 2021-06-30 | $-0.01B | $0.01B | -121.21% |
| 2021-03-31 | $-0.01B | $0.01B | -144.00% |
| 2020-12-31 | $-0.01B | $0.01B | -200.00% |
| 2020-09-30 | $-0.01B | $0.00B | -285.71% |
| 2020-06-30 | $0.00B | $0.00B | -200.00% |
| 2020-03-31 | $0.00B | $0.00B | -133.33% |
| 2019-12-31 | $0.00B | $0.00B | -66.67% |
| 2019-09-30 | $0.00B | $0.00B | -72.73% |
| 2019-06-30 | $0.00B | $0.00B | -44.44% |
| 2019-03-31 | $0.00B | $0.00B | -171.43% |
| 2018-12-31 | $0.00B | $0.00B | -400.00% |
| 2018-09-30 | $0.00B | $0.00B | -400.00% |
| 2018-06-30 | $0.00B | $0.00B | -800.00% |
| 2018-03-31 | $0.00B | $0.00B | 0.00% |
| 2017-12-31 | $0.00B | $0.00B | 0.00% |
| 2017-09-30 | $0.00B | $0.00B | 0.00% |
| 2017-06-30 | $0.00B | $0.00B | 0.00% |
| 2017-03-31 | $0.00B | $0.00B | 0.00% |
| 2016-12-31 | $0.00B | $0.00B | -400.00% |
| 2016-09-30 | $0.00B | $0.00B | -200.00% |
| 2016-06-30 | $0.00B | $0.00B | -200.00% |
| 2016-03-31 | $0.00B | $0.00B | -800.00% |
| 2015-12-31 | $0.00B | $0.00B | -1600.00% |
| 2015-09-30 | $0.00B | $0.00B | 0.00% |
| 2015-06-30 | $0.00B | $0.00B | 0.00% |
| 2015-03-31 | $0.00B | $0.00B | 0.00% |
| 2011-12-31 | $0.00B | $0.00B | 0.00% |
| 2011-09-30 | $0.00B | $0.00B | 0.00% |
| 2011-06-30 | $0.00B | $0.00B | 0.00% |
| 2011-03-31 | $0.00B | $0.00B | 0.00% |
| 2010-12-31 | $0.00B | $0.00B | 0.00% |
| 2010-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| 2010-03-31 | $0.00B | $0.00B | 0.00% |
| 2009-12-31 | $0.00B | $0.00B | 0.00% |
| 2009-09-30 | $-0.01B | $0.00B | 0.00% |
| 2009-06-30 | $0.00B | $0.00B | 0.00% |
| 2009-03-31 | $0.00B | $0.00B | 0.00% |
| 2008-12-31 | $0.00B | $0.00B | 0.00% |
| 2008-09-30 | $0.00B | $0.00B | 0.00% |
| 2008-06-30 | $0.00B | $0.00B | 0.00% |
| 2008-03-31 | $0.00B | $0.00B | 0.00% |
| 2007-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.003B | $0.007B |
| INVO Fertility Inc. is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics. INVO Fertility Inc., formerly known as NAYA Biosciences Inc., is based in SARASOTA, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $152.423B | 27.99 |
| HCA Healthcare (HCA) | United States | $105.496B | 17.47 |
| CVS Health (CVS) | United States | $101.390B | 11.66 |
| Cencora (COR) | United States | $70.781B | 22.83 |
| Elevance Health (ELV) | United States | $70.061B | 10.27 |
| Natera (NTRA) | United States | $28.530B | 0.00 |
| DiDi Global (DIDIY) | China | $25.745B | 21.04 |
| Labcorp Holdings (LH) | United States | $22.235B | 16.95 |
| Medpace Holdings (MEDP) | United States | $16.979B | 42.15 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.630B | 0.00 |
| ICON (ICLR) | Ireland | $13.197B | 13.10 |
| Viatris (VTRS) | United States | $12.900B | 4.81 |
| Solventum (SOLV) | United States | $12.814B | 12.44 |
| CochLear (CHEOY) | Australia | $12.308B | 0.00 |
| Revvity (RVTY) | United States | $10.692B | 19.69 |
| HealthEquity (HQY) | United States | $8.601B | 34.42 |
| Charles River Laboratories (CRL) | United States | $8.539B | 16.44 |
| Avantor (AVTR) | United States | $7.841B | 11.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.099B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.850B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.116B | 36.46 |
| Bausch + Lomb (BLCO) | Canada | $5.819B | 38.21 |
| Sotera Health (SHC) | United States | $4.582B | 22.10 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.044B | 71.02 |
| Alignment Healthcare (ALHC) | United States | $3.298B | 0.00 |
| Concentras Parent (CON) | United States | $2.510B | 15.66 |
| Premier (PINC) | United States | $2.325B | 22.54 |
| Progyny (PGNY) | United States | $2.053B | 40.36 |
| Surgery Partners (SGRY) | United States | $2.036B | 26.24 |
| Ardent Health (ARDT) | United States | $2.011B | 7.76 |
| Establishment Labs Holdings (ESTA) | $1.989B | 0.00 | |
| Organon (OGN) | United States | $1.955B | 2.06 |
| Pediatrix Medical (MD) | United States | $1.942B | 11.60 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.342B | 0.00 |
| Omada Health (OMDA) | $1.205B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.053B | 16.83 |
| CareDx (CDNA) | United States | $0.863B | 14.10 |
| Embecta (EMBC) | United States | $0.832B | 4.87 |
| InnovAge Holding (INNV) | United States | $0.735B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.647B | 8.92 |
| Nutex Health (NUTX) | United States | $0.622B | 9.42 |
| Sonida Senior Living (SNDA) | United States | $0.600B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.547B | 0.00 |
| Pomdoctor - (POM) | China | $0.536B | 0.00 |
| Charming Medical (MCTA) | $0.497B | 0.00 | |
| CryoPort (CYRX) | United States | $0.443B | 0.00 |
| So-Young (SY) | China | $0.431B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 18.16 |
| Auna S.A (AUNA) | Luxembourg | $0.386B | 5.80 |
| SBC Medicals (SBC) | United States | $0.353B | 7.73 |
| Oncology Institute (TOI) | United States | $0.314B | 0.00 |
| KindlyMD (NAKA) | United States | $0.308B | 0.00 |
| Agilon Health (AGL) | United States | $0.257B | 0.00 |
| LifeMD (LFMD) | United States | $0.240B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.231B | 0.00 |
| Beauty Health (SKIN) | United States | $0.166B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.142B | 0.00 |
| DocGo (DCGO) | United States | $0.108B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.101B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.50 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |